|
US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
WO1991015577A1
(en)
|
1990-04-04 |
1991-10-17 |
Black, Roy, A. |
INTERLEUKIN 1'beta' PROTEASE
|
|
DE69226820T2
(de)
|
1991-06-21 |
1999-05-12 |
Merck & Co., Inc., Rahway, N.J. |
Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen
|
|
RU2206611C2
(ru)
|
1991-08-30 |
2003-06-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
ФРАГМЕНТ ДНК, ПЛАЗМИДНЫЙ ВЕКТОР, СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА И ПОЛИПЕПТИД, ОБЛАДАЮЩИЙ IL-1β ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
|
|
GB9123326D0
(en)
|
1991-11-04 |
1991-12-18 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
AU1339092A
(en)
|
1991-12-13 |
1993-07-19 |
Corvas International, Inc. |
Reagents for automated synthesis of peptide analogs
|
|
AU3479593A
(en)
|
1992-01-31 |
1993-09-01 |
Merck & Co., Inc. |
Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme
|
|
CA2129976C
(en)
|
1992-02-21 |
2002-09-17 |
Kevin T. Chapman |
Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme
|
|
FR2698984B1
(fr)
|
1992-12-04 |
1995-01-06 |
Commissariat Energie Atomique |
Procédé et dispositif d'acquisition d'une image à trois dimensions d'un petit objet par palpage lumineux et moyen d'étalonnage pour la mise en Óoeuvre d'une telle acquisition.
|
|
CN1118458C
(zh)
|
1994-03-31 |
2003-08-20 |
弗特克斯药品有限公司 |
作为白细胞介素抑制剂的嘧啶基衍生物
|
|
US5552400A
(en)
|
1994-06-08 |
1996-09-03 |
Sterling Winthrop Inc. |
Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
|
|
US5716929A
(en)
|
1994-06-17 |
1998-02-10 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
|
US5565430A
(en)
|
1994-08-02 |
1996-10-15 |
Sterling Winthrop Inc. |
Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
|
|
CA2215211A1
(en)
|
1995-03-31 |
1996-10-03 |
Takeda Chemical Industries, Ltd. |
Cysteine protease inhibitor
|
|
US5798442A
(en)
|
1995-04-21 |
1998-08-25 |
Merck Frosst Canada, Inc. |
Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
|
|
EP0761680A3
(en)
|
1995-09-12 |
1999-05-06 |
Ono Pharmaceutical Co., Ltd. |
Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
|
|
US5744451A
(en)
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
|
WO1998001133A1
(en)
|
1996-07-08 |
1998-01-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Bone resorption inhibitors
|
|
ATE310528T1
(de)
|
1996-09-12 |
2005-12-15 |
Idun Pharmaceuticals Inc |
Hemmung der apoptose unter verwendung von inhibitoren der interleukin-1 beta converting enzym (ice)/ced-3 familie
|
|
US6200969B1
(en)
|
1996-09-12 |
2001-03-13 |
Idun Pharmaceuticals, Inc. |
Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US6610683B2
(en)
|
1996-09-12 |
2003-08-26 |
Idun Pharmaceuticals, Inc. |
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US6531467B2
(en)
|
1996-09-12 |
2003-03-11 |
Idun Pharmaceuticals, Inc. |
Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
US5968927A
(en)
|
1996-09-20 |
1999-10-19 |
Idun Pharmaceuticals, Inc. |
Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
|
|
CA2268098A1
(en)
|
1996-10-11 |
1998-04-23 |
Warner-Lambert Company |
Aspartate ester inhibitors of interleukin-1.beta. converting enzyme
|
|
US5919790A
(en)
|
1996-10-11 |
1999-07-06 |
Warner-Lambert Company |
Hydroxamate inhibitors of interleukin-1β converting enzyme
|
|
BR9712987A
(pt)
|
1996-10-11 |
2000-04-18 |
Warner Lambert Co |
Inibidores de enzima de conversão de interleucina-1beta de sulfonamida
|
|
EP0932600B1
(en)
|
1996-10-11 |
2006-02-08 |
Warner-Lambert Company Llc |
Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors
|
|
US6184244B1
(en)
|
1996-12-16 |
2001-02-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6184210B1
(en)
|
1997-10-10 |
2001-02-06 |
Cytovia, Inc. |
Dipeptide apoptosis inhibitors and the use thereof
|
|
DK1049703T3
(da)
|
1998-01-20 |
2003-06-02 |
Abbott Gmbh & Co Kg |
N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2--(4-fluorphenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-L-asparaginsyrealdehyd som en in vivo inhibitor af interleukin-1beta konverterende enzym
|
|
KR20010041905A
(ko)
|
1998-03-16 |
2001-05-25 |
시토비아 인크. |
디펩티드 카스파제 억제제 및 이의 용도
|
|
PL204619B1
(pl)
|
1998-03-19 |
2010-01-29 |
Vertex Pharma |
Pochodna peptydowa, kompozycja farmaceutyczna zawierająca taką pochodną i zastosowanie pochodnej peptydowej
|
|
BR9911010A
(pt)
|
1998-05-05 |
2005-12-06 |
Warner Lambert Co |
Inibidores de sucinamida de enzima de conversão da interleucina-1beta
|
|
US6197750B1
(en)
|
1998-07-02 |
2001-03-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
US6391575B1
(en)
*
|
1999-03-05 |
2002-05-21 |
Idun Pharmaceuticals, Inc. |
Methods for detecting membrane derived caspase activity and modulators thereof
|
|
EP1163214A1
(en)
|
1999-03-16 |
2001-12-19 |
Merck Frosst Canada & Co. |
Gamma-ketoacid dipeptides as inhibitors of caspase-3
|
|
EP1165490B1
(en)
|
1999-03-16 |
2006-08-16 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
CA2369619A1
(en)
|
1999-04-09 |
2000-10-19 |
Cytovia, Inc. |
Caspase inhibitors and the use thereof
|
|
ATE344249T1
(de)
|
1999-07-19 |
2006-11-15 |
Merck Frosst Canada Ltd |
Pyrazinone, diese verbindungen enthaltende zusammenstellungen
|
|
PT1163208E
(pt)
|
1999-08-06 |
2004-08-31 |
Vertex Pharma |
Inibidores de caspase e as suas utilizacoes
|
|
US6495522B1
(en)
|
1999-08-27 |
2002-12-17 |
Cytovia, Inc. |
Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
|
|
US6566338B1
(en)
|
1999-10-12 |
2003-05-20 |
Cytovia, Inc. |
Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
|
|
AR026748A1
(es)
|
1999-12-08 |
2003-02-26 |
Vertex Pharma |
Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis
|
|
US6689784B2
(en)
|
2000-03-29 |
2004-02-10 |
Vertex Pharmaceuticals Incorporated |
Carbamate caspase inhibitors and uses thereof
|
|
PE20011350A1
(es)
*
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
|
|
NZ516918A
(en)
|
2000-05-23 |
2004-06-25 |
Vertex Pharma |
Caspase inhibitors and uses thereof
|
|
DE60131160T2
(de)
|
2000-06-07 |
2008-08-07 |
Vertex Pharmaceuticals Inc., Cambridge |
Caspase-inhibitoren und ihre verwendungen
|
|
CA2315468A1
(en)
|
2000-08-10 |
2002-02-10 |
Thermax International Corp. |
Multi grouting system
|
|
JP2004509120A
(ja)
|
2000-09-13 |
2004-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
カスパーゼ阻害剤およびそれらの用途
|
|
EP1341767B1
(en)
|
2000-11-21 |
2007-04-11 |
Vertex Pharmaceuticals Incorporated |
Imidazole and benzimidazole caspase inhibitors and uses thereof
|
|
MXPA03009647A
(es)
|
2001-04-19 |
2004-01-29 |
Vertex Pharma |
Heterociclildicarbamidas como inhibidores de caspasa.
|
|
EP1392280A4
(en)
|
2001-05-10 |
2005-11-30 |
Warner Lambert Co |
ARYLSULFONAMIDE ETHERS AND METHODS OF USE THEREOF
|
|
CA2447999C
(en)
|
2001-05-23 |
2011-04-26 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
JP2005509028A
(ja)
|
2001-10-09 |
2005-04-07 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アスパラギン酸およびグルタミン酸誘導体ならびにそのジアゾケトン中間体を合成するための方法
|
|
EP1480999A2
(en)
|
2002-02-08 |
2004-12-01 |
Idun Pharmaceuticals |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
EP1485107A1
(en)
|
2002-02-11 |
2004-12-15 |
Vertex Pharmaceuticals Incorporated |
Phospholipids as caspase inhibitor prodrugs
|
|
GB0203446D0
(en)
*
|
2002-02-14 |
2002-04-03 |
Univ Lancaster |
Detection and/or monitoring of synuclein-related diseases
|
|
EP1494700A2
(en)
|
2002-04-05 |
2005-01-12 |
Cytovia, Inc. |
Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
|
|
US7001899B2
(en)
|
2002-06-10 |
2006-02-21 |
The Procter & Gamble Company |
Interleukin converting enzyme inhibitors
|
|
US7138395B2
(en)
|
2002-06-10 |
2006-11-21 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
|
US7041696B2
(en)
|
2002-06-17 |
2006-05-09 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
|
PE20040728A1
(es)
|
2002-06-28 |
2004-10-23 |
Vertex Pharma |
Inhibidores de caspasa
|
|
US7612091B2
(en)
|
2002-12-20 |
2009-11-03 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
DK2361928T3
(en)
*
|
2003-05-19 |
2017-07-03 |
Prothena Biosciences Ltd |
Truncated fragments of alpha synuclein in Lewy body disease
|
|
CA2531327A1
(en)
|
2003-07-03 |
2005-01-13 |
Myriad Genetics, Inc. |
Compounds and therapeutical use thereof
|
|
WO2005047860A2
(en)
*
|
2003-11-08 |
2005-05-26 |
Elan Pharmaceuticals, Inc. |
Antibodies to alpha-synuclein
|
|
US20050202508A1
(en)
|
2003-11-12 |
2005-09-15 |
Pasinetti Guilio M. |
Biomarker for Parkinson's disease
|
|
WO2005112913A1
(en)
|
2004-05-20 |
2005-12-01 |
The Scripps Research Institute |
Transthyretin stabilization
|
|
CN1980658A
(zh)
|
2004-05-27 |
2007-06-13 |
沃泰克斯药物股份有限公司 |
治疗自身炎性疾病的ice抑制剂
|
|
ATE531367T1
(de)
|
2004-09-17 |
2011-11-15 |
Whitehead Biomedical Inst |
Verbindungen, zusammensetzungen und verfahren zur verhinderung einer a-synuklein-vergiftung
|
|
RU2007125278A
(ru)
|
2005-02-08 |
2009-03-20 |
Зе Скрипс Ресеч Инститьют (Us) |
Ингибиторы образования амилоидных волокон транстиретина
|
|
US20070092889A1
(en)
|
2005-06-02 |
2007-04-26 |
Perlegen Sciences, Inc. |
Parkinson's disease-related disease compositions and methods
|
|
WO2007089548A2
(en)
|
2006-01-26 |
2007-08-09 |
Foldrx Pharmaceuticals, Inc. |
Compounds and methods for modulating protein trafficking
|
|
US20070197453A1
(en)
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Compositions and methods for treatment of disorders of protein aggregation
|
|
WO2008034016A2
(en)
|
2006-09-15 |
2008-03-20 |
Foldrx Pharmaceuticals, Inc. |
Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
|
|
US8450481B2
(en)
|
2007-06-14 |
2013-05-28 |
The Regents Of The University Of California |
Compounds for inhibiting protein aggregation, and methods for making and using them
|
|
EP2300000A1
(en)
*
|
2008-07-03 |
2011-03-30 |
University of Massachusetts |
Methods and compositions for reducing inflammation and treating inflammatory disorders
|
|
US20120276019A1
(en)
*
|
2008-07-25 |
2012-11-01 |
Diamedica Inc. |
Tissue kallikrein for the treatment of parkinson's disease
|
|
WO2010054127A1
(en)
|
2008-11-05 |
2010-05-14 |
Elan Pharmaceuticals, Inc. |
Methods and agents for stabilizing non-pathological amyloidogenic polypeptides
|
|
HRP20150831T1
(hr)
*
|
2008-12-19 |
2015-10-09 |
Biogen International Neuroscience Gmbh |
Humana anti-alfa- sinuklein auto-protutijela
|
|
US20130309690A1
(en)
*
|
2010-11-05 |
2013-11-21 |
The Brigham And Women's Hospital, Inc. |
Tetrameric alpha-synuclein as biomarkers
|
|
JP6006908B2
(ja)
|
2010-11-05 |
2016-10-12 |
ブランダイス ユニバーシティＢｒａｎｄｅｉｓ Ｕｎｉｖｅｒｓｉｔｙ |
Ｉｃｅ阻害化合物およびその使用
|